IBRNvsWDNA
iShares Neuroscience and Healthcare ETF against WisdomTree BioRevolution Fund — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | WDNA | |
|---|---|---|
| Expense ratio | 0.47% | 0.45% |
| Assets | $7864.21T | $2534.72T |
| Net flow, 1 month | +$2M | — |
| Net flow, 1 year | +$2M | — |
| Return, YTD | +24.7% | +39.9% |
| Return, 1 year | +57.5% | +61.6% |
| Avg daily volume | 3K | 2K |
| Holdings | 54 | 91 |
| Listed | Aug 23, 2022 | Jun 2, 2021 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS